SMAD4 and cancer: Indeed, previous work that linked SMAD4 polyubiquitination with its proteasomal degradation was largely done in cancer cell lines including with use of some cancer associated SMAD4 mutants [33, 49–51] (Fig. 2 and Supplementary Fig. 1).